Clinical Trial Update: A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluates the effectiveness of tirzepatide after initiation of ixekizumab in adults with active psoriatic arthritis who are overweig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Psoriatic Arthritis

Drugs mentioned

• Ixekizumab (ixekizumab)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Psoriatic Arthritis, Overweight or Obesity | Phase 4 | Status: RECRUITING